Centre Hospitalier Intercommunal De Poissy Saint Germain
- Address
- lock Available on a paid plan
Female Urogenital Diseases and Pregnancy Complications
At Centre Hospitalier Intercommunal De Poissy Saint Germain, clinical research in pregnancy complications focuses on protecting both mother and baby, especially in women with chronic hypertension and related risks.
- Prevention of preeclampsia and other maternal-fetal complications in high-risk pregnancies
- Study of pregnancy associated hypertension and its impact on outcomes such as fetal growth restriction
- Evaluation of a treatment approach aimed at reducing serious complications during pregnancy and delivery
This work is centered on improving safety in pregnancy and helping clinicians better prevent adverse outcomes for mothers and newborns.
Nervous System Diseases
Research in nervous system diseases at this site includes studies in multiple sclerosis, with attention to long-term disease control and treatment decisions in older patients.
- Secondary progressive multiple sclerosis and the effect of continuing or stopping disease-modifying therapies
- Assessment of disability progression in people with stable forms of multiple sclerosis
- Evidence generation to support treatment planning for patients with limited recent inflammatory activity
The goal is to better understand how to manage chronic neurologic disease while balancing effectiveness, safety, and quality of life.
Neoplasms
The oncology portfolio at Centre Hospitalier Intercommunal De Poissy Saint Germain includes research on follicular lymphoma and breast carcinoma, with a focus on improving survival and treatment selection.
- Testing new treatment combinations for previously untreated follicular lymphoma
- Evaluating whether adjuvant chemotherapy improves outcomes in older women with estrogen-receptor positive, HER2-negative breast cancer
- Studying ways to refine therapy for patients at higher risk of relapse
These trials aim to strengthen cancer care by comparing treatment strategies and identifying approaches that may offer better disease control.
Other Clinical Research Areas
This site also supports research that does not fit neatly into one therapeutic category, including studies focused on postoperative recovery and metabolic support after surgery.
- Prevention of post-thyroidectomy hypocalcemia after thyroidectomy
- Evaluation of cholecalciferol supplementation to improve recovery after surgery
- Research aimed at reducing discomfort, hospital stay, and perioperative burden
These studies reflect a practical interest in improving everyday patient care through better prevention and supportive treatment strategies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 16 therapeutic areas and 15 of 90 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 82 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 16 by active trials.
lock +15 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Intercommunal De Poissy Saint Germain
lock Showing 1 of 37 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Parallel-Group Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension | Novartis Pharma AG | Phase III | Not Recruiting | Jan 2022 | — |
IMP list
lock Showing 1 of 90 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ocrelizumab | 9 | Unknown | 2018-07-25 | 2026-06-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.